Physician profile
Ujjwal Datta
NPI 1760486385
$288.87
in general payments reported to CMS, 2019-2025
9 companies · $60.94 in 2025
The $60.94 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.68 · 2021: $32.71 · 2023: $178 · 2025: $60.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $148.65 | 2023 | Jublia |
| Exact Sciences Corporation | $25.59 | 2025 | The Cologuard Plus Collection Kit |
| Mckesson Medical-Surgical, INC. | $20.00 | 2021 | |
| Lilly USA, LLC | $19.37 | 2025 | Mounjaro, Zepbound |
| Bioventus LLC | $17.68 | 2019 | |
| Advanced Oxygen Therapy INC. | $15.98 | 2025 | Topical Oxygen Chamber For Extremities |
| Xeris Pharmaceuticals, INC. | $15.07 | 2023 | Gvoke Hypopen |
| Pfizer INC. | $13.82 | 2023 | |
| Merck Sharp & Dohme LLC | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ujjwal Datta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.